Repligen Corp (NASDAQ:RGEN) - Share price - Overview

Stock Report

Repligen Corp RGEN

Last Price
$40.31

Day Change
0.10|0.25%

As of 21/08/2017
16:14:31 EDT | USD
Minimum 15 Minutes Delay.

Last Close40.21
Day Range39.99 - 40.53
Mkt Cap1.73Bil
52-Wk Range26.16 - 46.81
Yield %-
ISINUS7599161095
Volume161,579
P/E79.04
P/S12.25
P/CF294.23

Share Price

Financials
201420152016
More ...
Income Statement
Revenue63.5583.54104.54
Operating Income10.6913.7615.97
Net Income8.179.3511.68
Basic EPS0.250.280.35
Avg. Diluted Shares Outstanding333434
Balance Sheet
Current Assets80.95103.25184.15
Non Current Assets47.3542.99104.76
Total Assets128.29146.24288.91
Current Liabilities10.6818.7821.08
Total Liabilities16.5623.49120.15
Total Equity111.73122.75168.76
Cash Flow
Operating Cash Flow18.4015.057.52
Capital Expenditure-5.60-2.63-4.33
Free Cash Flow12.8012.433.20

In millions, except "Basic EPS". Currency is USD.

Company Profile

Repligen Corp is a bioprocessing company developing, producing and commercializing biologic drugs. The company offers its products to life science companies, global biopharmaceutical companies, and contract manufacturers worldwide.

Sector

Healthcare

Industry

Biotechnology

Stock Style

Small-Growth

Fiscal Year Ends

December

Employees

236
Key Stats
More ...
Price/Earning TTM75.87
Price/Book9.07
Price/Sales TTM12.54
Rev Growth (3 year avg)15.32
EPS Growth (3 year avg)-
Operating Margin % TTM15.28
Net Margin % TTM11.17
ROE TTM8.01
Debt/Equity0.56
Dividends
PreviousLatest
More ...
Declared Datet.b.c.t.b.c.
Ex-Divt.b.c.t.b.c.
Paidt.b.c.t.b.c.
Amnt0.000.00
AJ Bell includes AJ Bell Holdings Limited and its wholly owned subsidiaries. AJ Bell Management Limited and AJ Bell Securities Limited are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2017 Morningstar. All rights reserved.